Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call
Rhea-AI Summary
Milestone Scientific (NYSE: MLSS) will hold a conference call at 8:30 AM ET on Wednesday, April 1, 2026 to discuss fourth quarter and full‑year 2025 financial results and corporate developments. The call includes a live webcast, telephone access, and an audio replay through April 15, 2026.
Telephone access codes and the webcast URL are provided for investors and analysts to listen live or via replay.
Positive
- None.
Negative
- None.
News Market Reaction – MLSS
On the day this news was published, MLSS declined 6.77%, reflecting a notable negative market reaction. Argus tracked a trough of -3.9% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $22.39M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed single-day moves (e.g., RVP +3.42%, NXGL -4.04%), with no momentum signals and no same-day peer news, indicating this looks stock-specific rather than a sector-wide move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 13 | Earnings call notice | Neutral | +6.0% | Announced Q3 2025 results and business update conference call details. |
| Aug 13 | Earnings call notice | Neutral | -3.6% | Scheduled Q2 2025 financial results and business update conference call. |
| Nov 12 | Earnings call notice | Neutral | +0.0% | Set date to review Q3 2024 financial results and corporate progress. |
| Aug 12 | Earnings call notice | Neutral | +5.2% | Announced Q2 2024 results call with access details and replay window. |
| May 13 | Earnings call notice | Neutral | -1.7% | Planned Q1 2024 results and business update conference call. |
Scheduling earnings/business update calls has historically led to modest, mixed price reactions, with both small gains and losses around these announcements.
Recent history for Milestone’s conferences,earnings announcements shows small but noticeable moves around call scheduling. Past events from 2024-05-13 through 2025-11-13 all followed the same pattern: setting a date and time to discuss quarterly results and corporate updates, with 24-hour moves ranging from about -3.56% to +6.03%. Today’s fourth-quarter and full-year 2025 call notice fits this established communication cadence.
Historical Comparison
In the past, MLSS scheduling earnings/business update calls led to average 24h moves of 1.19%. Today’s 2.11% gain is slightly above that but still within a historically modest range.
The company has consistently scheduled quarterly results and business update calls since at least early 2024, maintaining a regular investor communication pattern into the FY 2025 reporting cycle.
Market Pulse Summary
The stock moved -6.8% in the session following this news. A negative reaction despite this routine scheduling would fit a pattern of mixed responses to prior earnings call notices, where moves ranged from about -3.56% to modest gains. With MLSS trading well below its 0.45 200-day MA and carrying a disclosed going concern warning and increased authorized share count, regulatory and financing overhangs could amplify downside pressure following seemingly neutral news.
AI-generated analysis. Not financial advice.
ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2026, to discuss the company’s financial results for the fourth quarter and full year ended December 31, 2025, as well as the company’s corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 875878. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster5.com/Webcast/Page/2306/53250.
An audio replay of the call will be available through Wednesday, April 15th, 2026, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 53770.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2024. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason. Coding and payment decisions are determined solely by providers and payers based on applicable laws and policies. Any potential Category I designation is determined solely by the American Medical Association and is not guaranteed. Providers remain responsible for compliance with all applicable billing, coding, and regulatory requirements. Forward-looking case submission expectations, reimbursement targets, and revenue estimates referenced herein are based on current program enrollment, advisor commitments, and historical payer activity, and are subject to change based on clinical scheduling, payer processing timelines, regulatory developments, and other factors. There can be no assurance that Category I designation, targeted reimbursement levels, or projected revenue levels will be achieved.
Contact:
HAYDEN IR:
James Carbonara
(646)-755-7412
james@haydenir.com
Brett Maas
(646) 536-7331
brett@haydenir.com
FAQ
When will Milestone Scientific (MLSS) report Q4 and FY2025 results and hold the conference call?
How can investors join the Milestone Scientific (MLSS) April 1, 2026 conference call by phone?
Where is the Milestone Scientific (MLSS) webcast for the April 1, 2026 earnings call?
Will there be an audio replay of the Milestone Scientific (MLSS) April 1, 2026 call and how long will it be available?
What topics will Milestone Scientific (MLSS) cover on the April 1, 2026 conference call?
Does Milestone Scientific (MLSS) provide an access code for the live call and replay?
